NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
about
Pericytes, an overlooked player in vascular pathobiologyChimeric antigen receptor-modified T Cells inhibit the growth and metastases of established tissue factor-positive tumors in NOG miceRGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice.Cell surface expression of nucleolin mediates the antiangiogenic and antitumor activities of kallistatin.NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth.
P2860
NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
NG2 proteoglycan as a pericyte ...... with retargeted tissue factor.
@en
type
label
NG2 proteoglycan as a pericyte ...... with retargeted tissue factor.
@en
prefLabel
NG2 proteoglycan as a pericyte ...... with retargeted tissue factor.
@en
P2093
P2860
P356
P1433
P1476
NG2 proteoglycan as a pericyte ...... with retargeted tissue factor
@en
P2093
Caroline Brand
Christian Schwöppe
Christoph Schliemann
Eva Wardelmann
Heike Hintelmann
Janine Ring
Linus Angenendt
Rebecca Ross
Rolf M Mesters
Sebastian Bäumer
P2860
P304
P356
10.18632/ONCOTARGET.6725
P407
P577
2016-02-01T00:00:00Z